We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.AuthorsCurrier JR; Ngauy V; de Souza MS; Ratto-Kim S; Cox JH; Polonis VR; Earl P; Moss B; Peel S; Slike B; Sriplienchan S; Thongcharoen P; Paris RM; Robb ML; Kim J; Michael NL; Marovich MAPublicationPloS one, 2010, Vol 5, Issue 11, pe13983ISSN1932-6203Publication typearticleDOI10.1371/journal.pone.0013983